These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29514613)

  • 61. Pragmatic Trials.
    Ford I; Norrie J
    N Engl J Med; 2016 Aug; 375(5):454-63. PubMed ID: 27518663
    [No Abstract]   [Full Text] [Related]  

  • 62. Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent Validation.
    Eichler HG; Koenig F; Arlett P; Enzmann H; Humphreys A; Pétavy F; Schwarzer-Daum B; Sepodes B; Vamvakas S; Rasi G
    Clin Pharmacol Ther; 2020 Apr; 107(4):773-779. PubMed ID: 31574163
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The applicability of results of streamlined trials to clinical practice: the Myocarditis Treatment Trial.
    O'Connell JB; Mason JW
    Stat Med; 1990; 9(1-2):193-6; discussion 196-7. PubMed ID: 2345835
    [TBL] [Abstract][Full Text] [Related]  

  • 64. When Are Treatment Blinding and Treatment Standardization Necessary in Real-World Clinical Trials?
    Watanabe JH; Simon GE; Horberg M; Platt R; Hernandez A; Califf RM
    Clin Pharmacol Ther; 2022 Jan; 111(1):116-121. PubMed ID: 33829639
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Formulary restrictions may impact enrollment in pragmatic trials and limit generalizability of findings to vulnerable populations.
    Segal JB;
    Clin Trials; 2020 Dec; 17(6):729-731. PubMed ID: 32650667
    [No Abstract]   [Full Text] [Related]  

  • 66. Large pragmatic randomised controlled trials in peri-operative decision making: are they really the gold standard?
    Joshi GP; Alexander JC; Kehlet H
    Anaesthesia; 2018 Jul; 73(7):799-803. PubMed ID: 29577228
    [No Abstract]   [Full Text] [Related]  

  • 67. (Im)precise trial descriptions.
    Sessler DI
    Br J Anaesth; 2021 Dec; 127(6):824-825. PubMed ID: 34689991
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pragmatic surgical studies: are they the New Gold Standard.
    Simpson AHRW; Frost H; Norrie J
    Bone Joint J; 2018 Nov; 100-B(11):1407-1408. PubMed ID: 30418050
    [No Abstract]   [Full Text] [Related]  

  • 69. Randomised controlled trials do not always give the results we want but that doesn't mean we should abandon randomised controlled trials.
    Harvey LA
    Spinal Cord; 2015 Apr; 53(4):251. PubMed ID: 25858123
    [No Abstract]   [Full Text] [Related]  

  • 70. Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned.
    Degaga TS; Weston S; Tego TT; Abate DT; Aseffa A; Wayessa A; Price RN; Hailu A; Thriemer K
    Malar J; 2020 Jun; 19(1):205. PubMed ID: 32513176
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Commentary on the use of run-in periods in clinical trials.
    Franciosa JA
    Am J Cardiol; 1999 Mar; 83(6):942-4, A9. PubMed ID: 10190414
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Not Available].
    Messori A
    Recenti Prog Med; 2019 Nov; 110(11):533. PubMed ID: 31808438
    [No Abstract]   [Full Text] [Related]  

  • 73. Deriving Real-World Insights From Real-World Data: Biostatistics to the Rescue.
    Pencina MJ; Rockhold FW; D'Agostino RB
    Ann Intern Med; 2018 Sep; 169(6):401-402. PubMed ID: 30039173
    [No Abstract]   [Full Text] [Related]  

  • 74. Hard lessons from a randomised controlled trial.
    Pettigrew A
    Med J Aust; 2002 Aug; 177(4):223. PubMed ID: 12227332
    [No Abstract]   [Full Text] [Related]  

  • 75. The shrinking scope of pragmatic trials: a methodological reflection on their domain of applicability.
    Pawson R
    J Clin Epidemiol; 2019 Mar; 107():71-76. PubMed ID: 30500404
    [No Abstract]   [Full Text] [Related]  

  • 76. Randomised controlled trials in general practice. Internal validity of trials is more important than generalisability.
    Mant J; Dawes M; Graham-Jones S
    BMJ; 1996 Mar; 312(7033):779. PubMed ID: 8605490
    [No Abstract]   [Full Text] [Related]  

  • 77. Geography, generalisability, and susceptibility in clinical trials.
    Clougherty JE; Kinnee EJ; Cardet JC; Mauger D; Bacharier L; Beigelman A; Blake KV; Cabana MD; Castro M; Chmiel JF; Covar R; Fitzpatrick A; Gaffin JM; Gentile D; Israel E; Jackson DJ; Kraft M; Krishnan JA; Kumar HV; Lang JE; Lazarus SC; Lemanske RF; Lima J; Martinez FD; Morgan W; Moy J; Myers R; Naureckas ET; Ortega VE; Peters SP; Phipatanakul W; Pongracic JA; Ross K; Sheehan WJ; Smith LJ; Solway J; Sorkness CA; Wechsler ME; Wenzel S; White SR; Holguin F
    Lancet Respir Med; 2021 Apr; 9(4):330-332. PubMed ID: 33539731
    [No Abstract]   [Full Text] [Related]  

  • 78. Promoting Learning from Null or Negative Results in Prevention Science Trials.
    Axford N; Berry V; Lloyd J; Hobbs T; Wyatt K
    Prev Sci; 2022 Jul; 23(5):751-763. PubMed ID: 32748164
    [TBL] [Abstract][Full Text] [Related]  

  • 79. GLASS(Y) Half-Full: Moving Towards Greater Pragmatism in Outcome Ascertainment for Clinical Trials.
    Dhruva SS
    Circ Cardiovasc Qual Outcomes; 2021 Feb; 14(2):e007690. PubMed ID: 33535775
    [No Abstract]   [Full Text] [Related]  

  • 80. Achieving balance with power: lessons from the Balanced Anaesthesia Study.
    Spence J; Ioannidis JPA; Avidan MS
    Br J Anaesth; 2020 Apr; 124(4):366-370. PubMed ID: 31973826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.